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Objective: To test the hypothesis that aerobic-related leisure-time physical activity (PA) is 
associated with better cognitive function and that the effect varies among apolipoprotein E 
(APOE) genotype groups.
Design: Cross-sectional study of persons examined in the Third National Health and Nutrition 
Examination Survey (NHANES-III; 1988–1994).
Setting: US noninstitutionalized population.
Participants and methods: From a sample of 7159, aged $60 years, we analyzed data 
for 1799 older American men and women who had information on PA, a short mental status 
examination (SMSE), and were genotyped at the apolipoprotein E gene locus.
Results: In the initial bivariate analysis, non-ε4 carriers and ε4-heterozygotes performed better 
than ε4-homozygotes in the 60–69 age group. After controlling for multiple confounders includ-
ing mobility limitation, PA correlated with a higher SMSE score in non-ε4 carriers (P = 0.014), 
but not in ε4 carriers (P = 0.887). At $70 years, PA also correlated with higher adjusted SMSE 
scores in non-ε4 carriers (P = 0.02); but this association became nonsignificant after controlling 
for mobility limitation (P = 0.12).
Conclusion: In a nationally representative sample, PA was associated with enhanced cognition, 
an effect that was differentially influenced by apolipoprotein E genotype. Experimental studies 
are needed to determine whether or not PA can attenuate cognitive decline.
Keywords: cognition, physical activity, apolipoprotein E gene, aging
Introduction
Alzheimer’s disease (AD) is the most common type of dementia, constituting two-thirds 
of all late-life dementias.1,2 Its prevalence increases about 15-fold from 3% among 
individuals aged 65–74 years to 47% among persons aged $85 years.3–6 In 2010, the 
annual US health care cost for AD reached about US$144 billion.7 Similarly, total 
2010 health care, including long-term care payments for AD and other dementia care, 
was expected to reach US$172 billion.7 Given this cost and the projected increase in 
elderly population by the year 2050, identifying effective mechanisms to prevent AD 
is an important public health goal.
Until recently, the influence of lifestyle adaptation on AD risk had received very 
little attention in the scientific literature. Emerging evidence now indicates that PA 
can enhance cognitive processes.8–18 Whereas many of such studies examined the type 
of physical activities performed, others focused on the relationship of the number,19 
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frequency,20 or intensity21 of such activities with cognitive 
processes. A summary of published literature by Colcombe 
and Kramer, using a meta-analysis of 18 studies, concluded 
that   fitness training benefitted an array of neurocognitive 
process in nondemented older adults.22 Conclusions from 
these studies mostly suggest significant association of low 
and high levels of physical activity (PA) with reduced and 
enhanced cognitive processes, respectively; however, the 
sample sizes were often small, nonrepresentative, and lacked 
uniformity in their definition of PA and the characterization 
of the cognitive phenotype.
Despite the evidence showing that high levels of PA are 
mostly beneficial, significant interindividual variations of 
these benefits remain. This may suggest effect modifica-
tion at the genetic level. Variation at the apolipoprotein E 
(APOE) gene locus is the most consistent nondeterministic 
genetic risk factor for late-onset Alzheimer’s dementia.23–26 
Its contribution to AD risk is graded across its three known 
common isoforms (E2, E3, and E4) in humans encoded by 
ε2, ε3, and ε4 alleles. Whereas, ε2 allele is associated with 
lower risk, ε4 associates with increased AD risk, an effect 
that is differentially influenced by age.27–29 Interindividual 
variation in the ε4 allele-associated risk may also indicate 
additional effect modification at the environment level such 
as imposed by lifestyle. A prior longitudinal study examined 
the potential benefits of interactions between APOE and PA, 
with varying results.19 Whether the APOE gene modifies 
the effects of PA on cognition in a nationally representa-
tive sample such as the Third National Health and Nutri-
tion Examination Survey (NHANES-III) study is yet to be 
determined. We hypothesized that PA will associate with 
enhanced cognition and that this effect will differ with age 
and APOE genotype in a nationally representative sample 
of older Americans.
Methods
Study subjects
The NHANES-III was a cross-sectional, stratified, multistage 
probability sample of 33,994 civilian, noninstitutionalized 
Americans in the 50 states and the District of Columbia aged 
from 2 months to 99 years old, making it the first NHANES 
to include persons aged $75 years. The study, conducted by 
the Center for Disease Control’s National Center for Health 
Statistics between 1988 and 1994, oversampled Mexican 
Americans, African Americans, and those .60 years.30,31 Of 
persons aged $60 years, 5724 (86%) had an assessment of 
cognitive function. A subset of this sample (1799) included 
in this analysis were genotyped at the APOE locus.
General assessments
Overall, the questionnaires were designed for administration 
in a bilingual (English/Spanish) format so that respondents 
could be interviewed in their preferred language. During a 
home interview, an interviewer collected the demographic 
variables such as age, gender, and level of education to be 
used in this analysis.
PA
Participants were asked, “In the past month, did you engage 
in any leisure-time physical activity?” If their answer was 
“yes,” they were asked, “In the past month, how often did 
you …?” (specify number of times) for the following: 
  jogging or running, riding a bicycle or exercise bicycle, 
  swimming, aerobic dancing, other dancing, calisthenics 
or floor exercises, gardening or yard work, and weight 
lifting.32,33 Open-ended questions assessed up to four other 
activities. Participants were also asked about how often they 
walked $1 mile. Persons responding “no times” to all of the 
activities above were classified “no PA.” Mobility limitation 
was also categorized on the basis of participants’ responses 
to two questions asking about difficulty experienced walking 
two or three blocks and walking up to ten steps without 
resting. Persons reporting no difficulty were considered to 
not have limited mobility. These two questions have been 
used by other investigators to assess mobility limitation.34,35 
Serious chronic illnesses included a self-reported history 
of chronic obstructive pulmonary disease, congestive heart 
failure, myocardial infarction, cancer, diabetes, and stroke.
Assessment of cognitive function
Questions assessing mental cognition were asked only 
of respondents aged $60 years. The neuropsychological 
  measures used in the NHANES-III study were selected to 
assess cognitive functions typically affected in   dementia.36 
The evaluations, including measures of learning and memory, 
were obtained during home interviews and at the mobile 
examination center. These questions, along with recall 
questions and “serial 3 subtraction” found on the adult 
questionnaire, constituted a short mental state examination 
(SMSE).36,37 Details of the content and administration of the 
SMSE used during the NHANES-III have been previously 
published.38 Overall scores on the SMSE calculated from 
the sum of orientation, recall, and attention ranged from 
0 to 17. The SMSE was carried out during a home examina-
tion in 8.6% of the sample for participants who were unable 
or unwilling to come to a mobile examination center for a 
complete examination.
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Genetic data
Blood lymphocytes were collected from participants aged   
$12 years and stored in liquid nitrogen as cell cultures immor-
talized with Epstein–Barr virus. DNA in the form of crude cell 
lysates was made available for approved research projects for 
7159 persons examined between 1991 and 1994. Genetic data 
generated from those projects from 1999 to 2006 were submit-
ted to the National Center for Health Statistics and stored upon 
successful completion of a three-part quality-control analysis. 
We used data for participants genotyped at the APOE locus 
(dbSNP ID: rs7412 and rs429358). To maintain confidentiality 
of individual-level data, analysis occurred at the National 
Center for Health Statistics Research Data Center in Hyatts-
ville, MD. Approval of the Howard University Institutional 
Review Board was obtained prior to the analysis.
Statistical analysis
Initial analyses using SAS 9.2 (SAS Institute, Cary, NC) 
included t-test and chi-square test and examined for group 
differences in age, gender, ethnicity, educational attainment, 
and body mass by level of self-reported history of PA, as 
well as the effects of PA on cognition within age strata. 
Using multiple regression analysis, we then examined the 
relationship of PA to cognition, while adjusting for a priori 
defined confounders. Given the declining levels of PA with 
age and lower levels of PA in Blacks than in Whites, model 1 
included adjustment for age and ethnicity effects on cogni-
tion and physical function, whereas model 2 discounted the 
effects of chronic medical illnesses on cognitive processes 
and on PA levels. To discount the contribution of education 
on differences in performance on cognitive tasks39 and the 
association of body mass index (BMI) with cognition across 
populations,40,41 model 3 additionally adjusted for education 
and BMI. Given that persons with mobility limitation are 
less likely to exercise, this variable was included in model 4. 
Because of evidence indicating that the effect of APOE on 
cognition is probably influenced by age,27–29 and to further 
discern the effect of age from other predictors of cognitive 
outcome and important confounders, we constructed separate 
models for the age groups 60–69 and $70. Least square 
means adjusted for age, gender, ethnicity, and   education 
were derived using analysis of variance (general linear 
model). Similar, but separate, models were constructed for 
APOE genotype groups. To mitigate sample-size limitation, 
we dichotomized the sample as non-ε4 carriers (ε4 allele 
absent), and ε4 carriers (at least one copy of ε4).
To address the peculiarity of the multistage complex 
  survey design of NHANES-III, final analyses were performed 
using SUDAAN (RTI International, Research Triangle 
Park, NC), software that accounts for the multistage sam-
pling of NHANES-III in computing variance estimates.42 
  Appropriate sampling weights were used to account for 
oversampling and nonresponse. SUDAAN Proc Crosstab 
and Descript were used to estimate percentages and means, 
respectively, across groups. Proc Reg was used for linear 
regression.
Results
Overall, 56.9% had any PA, while 43.1% did not. Those who 
engaged in any PA were relatively younger, more likely to be 
men, and had more formal education (Table 1). Compared 
with other ethnic groups, Whites in the sample were about 
twice as likely to engage in PA as Blacks and Mexican 
Americans (61.6%, 32.8%, and 38.9%, respectively). 
However, both groups had comparable BMI. APOE 
genotype was in Hardy–Weinberg equilibrium (P , 0.05). 
The respective frequencies of allele combinations paralleled 
those reported in the literature. In the entire sample, Blacks 
were more likely to be carriers and homozygotes for the 
risk allele (ε4) (39.19 and 4.89, respectively), compared 
with Whites (28.02 and 2.19, respectively), and Mexican 
Americans (19.34 and 1.61), respectively.
Between the ages of 60 and 69 years (Figures 1 and 2), 
  persons who performed PA tended to score higher on the 
SMSE among heterozygotes and noncarriers but not among   
Table 1 Characteristics of the sample (percent by leisure-time 
physical activity)
Leisure-time  
physical activity
Yes No P value
Age (years)
  60–69 60.22 39.78 0.0134
 $ 70 53.66 46.34
Gender
  Men 56.89 43.11 ,0.0001
  Women 49.67 50.33
Ethnicity
  White 61.55 38.35 ,0.0001
  Black 32.81 67.19
  Mexican 38.94 61.06
  Other 32.22 67.78
Education (years)
 , 12 47.00 53.00 0.0002
  12 59.05 40.95
 . 12 66.67 33.33
Body mass index
 , 25 56.87 43.13 0.9651
  25–29 57.40 42.60
 $ 30 56.13 43.87
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homozygotes. At age $ 70 years, similar associations were 
observed not only in heterozygotes and noncarriers but also 
in homozygotes.
Multiple regression analysis
In the initial analysis restricted to the non-ε4 carrier genotype 
group aged 60–69 years and adjusted for age and ethnicity 
(model 1), PA was significantly associated with cognitive 
performance (β = 0.68 ± 0.2; P = 0.006) (Table 2). This model 
accounted for 9.8% of the observed variance. With additional 
adjustment for serious chronic medical illnesses (congestive 
heart failure, chronic obstructive pulmonary disease, cancer, 
diabetes, myocardial infarction, and stroke) (model 2), this 
statistically significant association remained unchanged 
(β = 0.68 ± 0.2; P = 0.007). However, after accounting for 
differences in BMI and education (model 3), PA maintained a 
statistically significant but reduced association with cognitive 
function (β = 0.52 ± 0.2; P = 0.007). In the last model, controlled 
for mobility limitation in non-ε4 carriers (model 4), the signifi-
cant association of PA (β coefficient 0.43 ± 0.2, P = 0.014) with 
SMSE score persisted though slightly attenuated. However, 
among the ε4 carriers of this age group, PA did not significantly 
associate with cognitive performance.
We also examined the relationship of PA to SMSE in 
the .70 year old age group (Table 3). In noncarriers, PA 
associated with performance on the cognitive test in models 
1, 2, and 3. With the introduction of mobility limitation 
(β = −0.78 ± 0.2, P , 0.001) in model 4, the association 
of PA to cognitive performance became attenuated and 
nonsignificant (β = 0.37 ± 0.2, P = 0.117). Among ε4 carriers, 
similar associations with cognitive performance were observed 
in models 1–4, but did not attain statistical significance. This 
could be due to the smaller sample size.
Discussion
PA was associated with better performance on cognitive tasks 
in a sample of age $ 60 non-ε4 carriers but not in   carriers. 
These findings were independent of linear age, gender, 
ethnicity, education, income, and history of serious chronic 
illness. This adds to growing evidence that increased levels 
of PA may offer an important primary intervention strategy 
to attenuate neurocognitive loss, especially in non-ε4 carriers. 
Delay in significant cognitive loss and considerable public 
heath impact are likely to be realized if these findings are 
confirmed in experimental studies.
Evidence showing that PA can enhance cognition includes 
cross-sectional, prospective studies and a limited number of 
controlled trials.8–11,17–20,22 Many studies examined the effects 
of aerobic fitness on cognition in nondemented older adults, 
while others determined whether or not lifestyle factors can 
reduce or delay late-onset Alzheimer’s dementia. In concor-
dance with our observations from this study, a beneficial 
effect of PA was often reported.19–21,43 Whereas Albert and 
colleagues reported that strenuous but not moderate inten-
sity daily PA enhanced cognition,44 Yaffe et al showed that 
moderate daily PA can also improve cognitive processes.45 
Together, these reports are consistent with our hypothesis and 
results from this study that PA is beneficial to cognitive health.   
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Figure 1 Mean short mental state examination (SMSE) score by physical activity and 
apolipoprotein E genotype (age 60 to 69 years).
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Figure 2 Mean short mental state examination (SMSE) score by leisure-time physical 
activity and apolipoprotein E genotype (age $ 70 years).
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
38
Obisesan et alClinical Interventions in Aging 2012:7
T
a
b
l
e
 
2
 
R
e
g
r
e
s
s
i
o
n
 
a
n
a
l
y
s
i
s
 
d
e
p
e
n
d
e
n
t
 
v
a
r
i
a
b
l
e
:
 
s
h
o
r
t
 
m
e
n
t
a
l
 
s
t
a
t
e
 
e
x
a
m
i
n
a
t
i
o
n
 
(
a
g
e
 
6
0
–
6
9
 
y
e
a
r
s
)
V
a
r
i
a
b
l
e
s
A
g
e
 
a
n
d
 
e
t
h
n
i
c
i
t
y
 
a
d
j
u
s
t
e
d
 
 
(
m
o
d
e
l
 
1
)
M
o
d
e
l
 
1
 
p
l
u
s
 
c
h
r
o
n
i
c
 
d
i
s
e
a
s
e
 
 
(
m
o
d
e
l
 
2
)
M
o
d
e
l
 
2
 
p
l
u
s
 
e
d
u
c
a
t
i
o
n
 
a
n
d
 
B
M
I
 
 
(
m
o
d
e
l
 
3
)
M
o
d
e
l
 
3
 
p
l
u
s
 
m
o
b
i
l
i
t
y
 
l
i
m
i
t
a
t
i
o
n
 
(
m
o
d
e
l
 
4
)
β
9
5
%
 
C
I
P
 
v
a
l
u
e
β
9
5
%
 
C
I
P
 
v
a
l
u
e
β
9
5
%
 
C
I
P
 
v
a
l
u
e
β
9
5
%
 
C
I
P
 
v
a
l
u
e
N
o
n
-
ε
4
 
c
a
r
r
i
e
r
s
 
(
n
 
=
 
5
8
5
)
R
-
s
q
u
a
r
e
d
 
(
%
)
(
9
.
8
)
(
9
.
6
)
(
1
6
.
1
)
(
1
7
.
5
)
A
e
r
o
b
i
c
 
a
c
t
i
v
i
t
y
0
.
6
8
 
±
 
0
.
2
3
0
.
2
1
 
±
 
1
.
1
5
0
.
0
0
6
0
.
6
8
 
±
 
0
.
2
3
0
.
2
1
 
±
 
1
.
1
5
0
.
0
0
7
0
.
5
2
 
±
 
0
.
1
8
0
.
1
6
 
±
 
0
.
8
9
0
.
0
0
7
0
.
4
3
 
±
 
0
.
1
6
0
.
1
0
 
±
 
0
.
7
6
0
.
0
1
4
A
g
e
−
0
.
0
4
 
±
 
0
.
0
3
0
.
0
3
 
±
 
−
0
.
0
9
0
.
1
4
4
−
0
.
0
4
 
±
 
0
.
0
2
−
0
.
0
9
 
±
 
0
.
0
1
0
.
1
2
5
−
0
.
0
3
 
±
 
0
.
0
2
−
0
.
0
8
 
±
 
0
.
0
2
0
.
1
9
8
−
0
.
0
3
 
±
 
0
.
0
2
−
0
.
0
8
 
±
 
0
.
0
2
0
.
2
2
4
E
t
h
n
i
c
i
t
y
 
W
h
i
t
e
s
0
.
2
4
 
±
 
0
.
4
0
0
.
4
0
 
±
 
−
0
.
5
8
0
.
5
5
0
0
.
2
3
 
±
 
0
.
4
1
−
0
.
6
1
 
±
 
1
.
0
7
0
.
5
7
7
0
.
2
7
 
±
 
0
.
3
7
−
0
.
4
9
 
±
 
1
.
0
3
0
.
4
7
5
0
.
2
8
 
±
 
0
.
3
8
−
0
.
5
0
 
±
 
1
.
0
5
0
.
4
6
6
 
B
l
a
c
k
−
0
.
9
4
 
±
 
0
.
5
3
0
.
5
3
 
±
 
−
2
.
0
3
0
.
0
8
9
−
0
.
9
4
 
±
 
0
.
5
4
−
2
.
0
6
 
±
 
0
.
1
8
0
.
0
9
5
−
0
.
6
8
 
±
 
0
.
5
2
−
1
.
7
6
 
±
 
0
.
4
0
0
.
2
0
6
−
0
.
6
1
 
±
 
0
.
5
2
−
1
.
6
9
 
±
 
0
.
4
7
0
.
2
5
3
 
H
i
s
p
a
n
i
c
−
1
.
1
3
 
±
 
0
.
4
9
0
.
4
9
 
±
 
−
2
.
1
4
0
.
0
2
9
−
1
.
1
3
 
±
 
0
.
4
9
−
2
.
1
4
 
±
 
0
.
1
2
0
.
0
3
0
−
0
.
7
0
 
±
 
0
.
4
9
−
1
.
7
0
 
±
 
0
.
3
1
0
.
1
6
6
−
0
.
7
0
 
±
 
0
.
5
1
−
1
.
7
5
 
±
 
0
.
3
6
0
.
1
8
5
C
h
r
o
n
i
c
 
d
i
s
e
a
s
e
−
0
.
0
8
 
±
 
0
.
3
8
−
0
.
8
6
 
±
 
0
.
7
0
0
.
8
3
7
0
.
0
7
 
±
 
0
.
4
1
−
0
.
7
7
 
±
 
0
.
9
2
0
.
8
5
7
0
.
1
0
 
±
 
0
.
4
0
−
0
.
7
3
 
±
 
0
.
9
3
0
.
8
0
3
L
o
g
B
M
I
0
.
3
7
 
±
 
0
.
6
9
−
1
.
0
5
 
±
 
1
.
8
0
0
.
5
9
3
0
.
5
0
 
±
 
0
.
6
9
−
0
.
9
3
 
±
 
1
.
9
4
0
.
4
7
6
E
d
u
c
a
t
i
o
n
0
.
6
0
 
±
 
0
.
1
2
0
.
3
6
 
±
 
0
.
8
4
,
0
.
0
0
1
0
.
5
6
 
±
 
0
.
1
1
0
.
3
4
 
±
 
0
.
7
8
,
0
.
0
0
1
M
o
b
i
l
i
t
y
 
l
i
m
i
t
a
t
i
o
n
−
0
.
5
1
 
±
 
0
.
3
0
−
1
.
1
3
 
±
 
0
.
1
0
.
1
0
0
ε
4
 
c
a
r
r
i
e
r
s
 
(
n
 
=
 
2
1
0
)
R
-
s
q
u
a
r
e
d
 
(
%
)
(
5
.
7
)
(
7
.
8
)
(
1
8
.
2
)
(
1
8
.
5
)
A
e
r
o
b
i
c
 
a
c
t
i
v
i
t
y
0
.
1
5
 
±
 
0
.
2
4
−
0
.
3
5
 
±
 
0
.
6
4
0
.
5
3
9
0
.
1
8
 
±
 
0
.
2
4
−
0
.
3
2
 
±
 
0
.
6
8
0
.
4
6
4
0
.
0
1
 
±
 
0
.
2
3
−
0
.
4
7
 
±
 
0
.
5
0
0
.
9
5
0
0
.
0
4
 
±
 
0
.
2
6
−
0
.
5
7
 
±
 
0
.
4
9
0
.
8
8
7
A
g
e
−
0
.
0
4
 
±
 
0
.
0
4
−
0
.
1
2
 
±
 
0
.
0
5
0
.
3
8
0
−
0
.
0
4
 
±
 
0
.
0
4
−
0
.
1
3
 
±
 
0
.
0
5
0
.
4
0
2
−
0
.
0
5
 
±
 
0
.
0
4
−
0
.
1
3
 
±
 
0
.
0
3
0
.
2
4
3
−
0
.
0
5
 
±
 
0
.
0
4
−
0
.
1
3
 
±
 
0
.
0
4
0
.
2
6
0
E
t
h
n
i
c
i
t
y
 
W
h
i
t
e
0
.
0
5
 
±
 
0
.
5
2
−
1
.
0
3
 
±
 
1
.
1
3
0
.
9
2
4
0
.
0
3
 
±
 
0
.
4
9
−
0
.
9
7
 
±
 
1
.
0
4
0
.
9
4
9
−
0
.
2
8
 
±
 
0
.
4
5
−
1
.
2
2
 
±
 
0
.
6
6
0
.
5
4
1
−
0
.
2
7
 
±
 
0
.
4
5
−
1
.
2
0
 
±
 
0
.
6
6
0
.
5
5
4
 
B
l
a
c
k
−
0
.
5
6
 
±
 
0
.
5
6
−
1
.
7
1
 
±
 
0
.
5
9
0
.
3
2
3
−
0
.
5
4
 
±
 
0
.
5
0
−
1
.
5
8
 
±
 
0
.
5
1
0
.
3
0
0
−
0
.
7
7
 
±
 
0
.
4
3
−
1
.
6
7
 
±
 
0
.
1
2
0
.
8
6
1
−
0
.
7
7
 
±
 
0
.
4
2
−
1
.
6
4
 
±
 
0
.
1
1
0
.
0
8
3
 
H
i
s
p
a
n
i
c
−
1
.
8
6
 
±
 
0
.
8
1
−
3
.
5
4
 
±
 
−
0
.
1
8
0
.
3
1
6
−
1
.
7
6
 
±
 
0
.
7
8
−
3
.
3
8
 
±
 
−
0
.
1
4
0
.
0
3
4
−
1
.
6
6
 
±
 
0
.
6
4
−
2
.
9
9
 
±
 
−
0
.
3
3
0
.
0
1
7
−
1
.
5
7
 
±
 
0
.
6
4
−
2
.
8
9
 
±
 
−
0
.
2
4
0
.
0
2
3
C
h
r
o
n
i
c
 
d
i
s
e
a
s
e
−
0
.
7
2
 
±
 
0
.
3
2
−
1
.
3
9
 
±
 
−
0
.
0
5
0
.
0
3
5
−
0
.
7
3
 
±
 
0
.
2
3
−
1
.
2
1
 
±
 
−
0
.
2
6
0
.
0
0
4
−
0
.
7
1
 
±
 
0
.
2
3
−
1
.
1
8
 
±
 
−
0
.
2
3
0
.
0
0
6
L
o
g
B
M
I
0
.
3
4
 
±
 
0
.
7
7
−
1
.
2
6
 
±
 
1
.
9
4
0
.
6
6
1
0
.
4
1
 
±
 
0
.
7
2
−
1
.
0
8
 
±
 
1
.
9
1
0
.
5
7
4
E
d
u
c
a
t
i
o
n
0
.
7
3
 
±
 
0
.
3
1
0
.
0
9
 
±
 
1
.
3
6
0
.
0
2
7
0
.
7
2
 
±
 
0
.
3
1
0
.
0
7
 
±
 
1
.
3
6
0
.
0
3
2
M
o
b
i
l
i
t
y
 
l
i
m
i
t
a
t
i
o
n
−
0
.
2
4
 
±
 
0
.
3
8
−
1
.
0
3
 
±
 
0
.
5
6
0
.
5
4
5
N
o
t
e
s
:
 
S
i
g
n
i
fi
c
a
n
t
 
l
e
v
e
l
 
f
o
r
 
a
l
p
h
a
 
w
a
s
 
s
e
t
 
a
t
 
,
0
.
0
5
;
 
m
o
d
e
l
 
P
 
v
a
l
u
e
s
 
a
r
e
 
a
l
l
 
,
0
.
0
0
0
1
;
 
s
e
r
i
o
u
s
 
c
h
r
o
n
i
c
 
i
l
l
n
e
s
s
e
s
 
i
n
c
l
u
d
e
d
 
h
i
s
t
o
r
y
 
o
f
 
c
h
r
o
n
i
c
 
o
b
s
t
r
u
c
t
i
v
e
 
p
u
l
m
o
n
a
r
y
 
d
i
s
e
a
s
e
,
 
c
o
n
g
e
s
t
i
v
e
 
h
e
a
r
t
 
f
a
i
l
u
r
e
,
 
m
y
o
c
a
r
d
i
a
l
 
i
n
f
a
r
c
t
i
o
n
,
 
c
a
n
c
e
r
,
 
d
i
a
b
e
t
e
s
,
 
a
n
d
 
s
t
r
o
k
e
.
A
b
b
r
e
v
i
a
t
i
o
n
s
:
 
B
M
I
,
 
b
o
d
y
 
m
a
s
s
 
i
n
d
e
x
;
 
C
I
,
 
c
o
n
fi
d
e
n
c
e
 
i
n
t
e
r
v
a
l
.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
39
Physical activity, cognition, and apolipoprotein E geneClinical Interventions in Aging 2012:7
T
a
b
l
e
 
3
 
R
e
g
r
e
s
s
i
o
n
 
a
n
a
l
y
s
i
s
 
d
e
p
e
n
d
e
n
t
 
v
a
r
i
a
b
l
e
:
 
s
h
o
r
t
 
m
e
n
t
a
l
 
s
t
a
t
e
 
e
x
a
m
i
n
a
t
i
o
n
 
(
a
g
e
 
$
 
7
0
 
y
e
a
r
s
)
V
a
r
i
a
b
l
e
s
A
g
e
 
a
n
d
 
e
t
h
n
i
c
i
t
y
 
a
d
j
u
s
t
e
d
 
(
m
o
d
e
l
 
1
)
M
o
d
e
l
 
1
 
p
l
u
s
 
c
h
r
o
n
i
c
 
d
i
s
e
a
s
e
 
(
m
o
d
e
l
 
2
)
M
o
d
e
l
 
2
 
p
l
u
s
 
e
d
u
c
a
t
i
o
n
 
a
n
d
 
B
M
I
 
(
m
o
d
e
l
 
3
)
M
o
d
e
l
 
3
 
p
l
u
s
 
m
o
b
i
l
i
t
y
 
l
i
m
i
t
a
t
i
o
n
 
(
m
o
d
e
l
 
4
)
β
9
5
%
 
C
I
P
 
v
a
l
u
e
β
9
5
%
 
C
I
P
 
v
a
l
u
e
β
9
5
%
 
C
I
P
 
v
a
l
u
e
β
9
5
%
 
C
I
P
 
v
a
l
u
e
N
o
n
-
ε
4
 
c
a
r
r
i
e
r
s
 
(
n
 
=
 
7
0
0
)
R
-
s
q
u
a
r
e
d
 
(
%
)
(
1
2
.
7
)
(
1
3
.
3
)
(
1
8
.
9
)
(
2
1
.
1
)
A
e
r
o
b
i
c
 
a
c
t
i
v
i
t
y
0
.
6
7
 
±
 
0
.
2
3
0
.
2
0
,
 
1
.
1
5
0
.
0
0
7
0
.
6
3
 
±
 
0
.
2
5
0
.
1
2
,
 
1
.
1
5
0
.
0
1
8
0
.
5
6
 
±
 
0
.
2
3
0
.
0
9
,
 
1
.
0
3
0
.
0
2
2
0
.
3
7
 
±
 
0
.
2
3
−
0
.
1
0
,
 
0
.
8
5
0
.
1
1
7
A
g
e
−
0
.
0
8
 
±
 
0
.
0
1
−
0
.
1
1
,
 
−
0
.
0
5
,
0
.
0
0
1
−
0
.
0
7
 
±
 
0
.
0
1
−
0
.
1
0
,
 
−
0
.
0
4
,
0
.
0
0
1
−
0
.
0
6
 
±
 
0
.
0
2
−
0
.
0
9
,
 
−
0
.
0
2
0
.
0
0
2
−
0
.
0
4
 
±
 
0
.
0
2
−
0
.
0
8
,
 
−
0
.
0
1
0
.
0
2
4
E
t
h
n
i
c
i
t
y
 
W
h
i
t
e
0
.
7
3
 
±
 
0
.
9
5
−
1
.
2
3
,
 
2
.
6
9
0
.
4
4
6
0
.
7
7
 
±
 
0
.
9
4
−
1
.
1
8
,
 
2
.
7
2
0
.
4
2
0
0
.
3
0
 
±
 
0
.
7
9
−
1
.
3
4
,
 
1
.
9
3
0
.
7
1
1
0
.
3
4
 
±
 
0
.
6
9
−
1
.
1
0
,
 
1
.
7
8
0
.
6
2
9
 
B
l
a
c
k
−
1
.
4
0
 
±
 
0
.
9
7
−
3
.
4
1
,
 
0
.
6
1
0
.
1
6
3
−
1
.
3
2
 
±
 
0
.
9
6
−
3
.
3
0
,
 
0
.
6
6
0
.
1
8
0
−
1
.
2
4
 
±
 
0
.
7
9
−
2
.
8
8
,
 
0
.
4
1
0
.
1
3
3
−
1
.
2
0
 
±
 
0
.
6
9
−
2
.
6
3
,
 
0
.
2
2
0
.
0
9
4
 
H
i
s
p
a
n
i
c
−
1
.
2
5
 
±
 
1
.
0
3
−
3
.
3
9
,
 
0
.
8
9
0
.
2
3
8
−
1
.
1
1
 
±
 
1
.
0
4
−
3
.
2
7
,
 
1
.
0
5
0
.
2
9
7
−
1
.
0
7
 
±
 
0
.
8
9
−
2
.
9
1
,
 
0
.
7
7
0
.
2
4
1
−
1
.
0
1
 
±
 
0
.
7
9
−
2
.
6
5
,
 
0
.
6
2
0
.
2
1
2
C
h
r
o
n
i
c
 
d
i
s
e
a
s
e
−
0
.
6
1
 
±
 
0
.
3
9
−
1
.
4
1
,
 
0
.
1
9
0
.
1
3
0
−
0
.
6
1
 
±
 
0
.
4
1
−
1
.
4
6
,
 
0
.
2
5
0
.
1
5
8
−
0
.
5
2
 
±
 
0
.
3
9
−
1
.
3
2
,
 
0
.
2
8
0
.
1
8
9
L
o
g
B
M
I
0
.
7
5
 
±
 
0
.
7
4
−
0
.
7
9
,
 
2
.
2
8
0
.
3
2
4
0
.
9
6
 
±
 
0
.
7
7
−
0
.
6
4
,
 
2
.
5
5
0
.
2
2
7
E
d
u
c
a
t
i
o
n
−
0
.
6
1
 
±
 
0
.
4
1
−
1
.
4
6
,
 
0
.
2
5
0
.
1
5
8
0
.
6
9
 
±
 
0
.
1
1
0
.
4
6
,
 
0
.
9
1
,
0
.
0
0
1
M
o
b
i
l
i
t
y
 
l
i
m
i
t
a
t
i
o
n
0
.
3
7
 
±
 
0
.
2
−
1
.
1
1
,
 
−
0
.
4
6
0
.
1
1
7
ε
4
 
C
a
r
r
i
e
r
s
 
(
n
 
=
 
2
1
4
)
R
-
s
q
u
a
r
e
d
 
(
%
)
(
1
6
.
9
)
(
1
7
.
6
)
(
2
1
.
2
)
(
2
2
.
6
)
A
e
r
o
b
i
c
 
a
c
t
i
v
i
t
y
0
.
5
2
 
±
 
0
.
3
3
−
0
.
1
7
,
 
1
.
2
1
0
.
1
3
6
0
.
6
9
 
±
 
0
.
3
6
−
0
.
0
6
,
 
1
.
4
3
0
.
0
6
7
0
.
5
8
 
±
 
0
.
3
5
−
0
.
1
4
,
 
1
.
3
0
0
.
1
0
9
0
.
3
1
 
±
 
0
.
4
2
−
0
.
5
6
,
 
1
.
1
7
0
.
4
7
0
A
g
e
−
0
.
1
8
 
±
 
0
.
0
5
−
0
.
2
8
,
 
−
0
.
0
8
0
.
0
0
1
−
0
.
1
7
 
±
 
0
.
0
5
−
0
.
2
7
,
 
−
0
.
0
8
0
.
0
0
1
−
0
.
1
6
 
±
 
0
.
0
4
−
0
.
2
4
,
 
−
0
.
0
7
0
.
0
0
1
−
0
.
1
4
 
±
 
0
.
0
4
−
0
.
2
3
,
 
−
0
.
0
5
0
.
0
0
3
E
t
h
n
i
c
i
t
y
 
W
h
i
t
e
s
1
.
2
9
 
±
 
1
.
3
7
−
1
.
5
5
,
 
4
.
1
3
0
.
3
5
8
1
.
4
8
 
±
 
1
.
4
0
−
1
.
4
2
,
 
4
.
3
8
0
.
3
0
2
1
.
2
2
 
±
 
1
.
5
9
−
2
.
0
7
,
 
4
.
5
1
0
.
4
5
2
1
.
2
9
 
±
 
1
.
6
1
−
2
.
0
4
,
 
4
.
6
3
0
.
4
3
1
 
B
l
a
c
k
s
0
.
0
7
 
±
 
1
.
4
2
−
2
.
8
7
,
 
3
.
0
0
.
9
6
3
0
.
2
2
 
±
 
1
.
4
3
−
2
.
7
5
,
 
3
.
1
8
0
.
8
8
2
0
.
1
2
 
±
 
1
.
5
0
−
2
.
9
9
,
 
3
.
2
2
0
.
9
3
8
0
.
2
8
 
±
 
1
.
5
3
−
2
.
9
0
,
 
3
.
4
5
0
.
8
5
8
 
H
i
s
p
a
n
i
c
0
.
7
3
 
±
 
1
.
3
2
−
1
.
9
9
,
 
3
.
4
6
0
.
5
8
2
0
.
8
3
 
±
 
1
.
3
4
−
1
.
9
5
,
 
3
.
6
0
0
.
5
4
3
0
.
8
2
 
±
 
1
.
3
4
−
1
.
9
6
,
 
3
.
5
9
0
.
5
4
9
0
.
8
1
 
±
 
1
.
3
4
−
1
.
9
6
,
 
3
.
5
8
0
.
5
5
0
C
h
r
o
n
i
c
 
d
i
s
e
a
s
e
0
.
7
0
 
±
 
0
.
5
0
−
0
.
3
3
,
 
1
.
7
2
0
.
1
7
4
0
.
5
3
 
±
 
0
.
4
8
−
0
.
4
6
,
 
1
.
5
2
0
.
2
8
0
0
.
5
4
 
±
 
0
.
5
0
−
0
.
4
9
,
 
1
.
5
7
0
.
2
8
9
L
o
g
B
M
I
2
.
1
8
 
±
 
0
.
9
3
0
.
2
5
,
 
4
.
1
1
0
.
0
2
9
2
.
4
6
 
±
 
0
.
9
8
0
.
4
3
,
 
4
.
5
0
0
.
0
2
0
E
d
u
c
a
t
i
o
n
2
.
1
8
 
±
 
0
.
9
3
0
.
2
5
,
 
4
.
1
1
0
.
0
2
9
0
.
4
1
 
±
 
0
.
3
0
−
0
.
2
1
,
 
1
.
0
2
0
.
1
8
3
M
o
b
i
l
i
t
y
 
l
i
m
i
t
a
t
i
o
n
−
0
.
7
7
 
±
 
0
.
4
9
−
1
.
8
0
,
 
0
.
2
5
0
.
1
3
3
N
o
t
e
s
:
 
S
i
g
n
i
fi
c
a
n
t
 
l
e
v
e
l
 
f
o
r
 
a
l
p
h
a
 
w
a
s
 
s
e
t
 
a
t
 
,
0
.
0
5
;
 
m
o
d
e
l
 
P
 
v
a
l
u
e
s
 
a
r
e
 
a
l
l
 
,
0
.
0
0
0
1
;
 
s
e
r
i
o
u
s
 
c
h
r
o
n
i
c
 
i
l
l
n
e
s
s
e
s
 
i
n
c
l
u
d
e
d
 
h
i
s
t
o
r
y
 
o
f
 
c
h
r
o
n
i
c
 
o
b
s
t
r
u
c
t
i
v
e
 
p
u
l
m
o
n
a
r
y
 
d
i
s
e
a
s
e
,
 
c
o
n
g
e
s
t
i
v
e
 
h
e
a
r
t
 
f
a
i
l
u
r
e
,
 
m
y
o
c
a
r
d
i
a
l
 
i
n
f
a
r
c
t
i
o
n
,
 
c
a
n
c
e
r
,
 
d
i
a
b
e
t
e
s
,
 
a
n
d
 
s
t
r
o
k
e
.
A
b
b
r
e
v
i
a
t
i
o
n
s
:
 
B
M
I
,
 
b
o
d
y
 
m
a
s
s
 
i
n
d
e
x
;
 
C
I
,
 
c
o
n
fi
d
e
n
c
e
 
i
n
t
e
r
v
a
l
.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
40
Obisesan et alClinical Interventions in Aging 2012:7
However, unlike previous cross-sectional studies, the use of a 
representative sample of US noninstitutionalized population 
enhanced the generalizability of our findings beyond that 
previously reported in cross-sectional studies.
Consistent with our second hypothesis, the relationship 
of PA to performance on the SMSE test varied with APOE 
genotype and age group. In the adjusted model, the apparent 
relationship between APOE and PA observed in the unad-
justed model became attenuated in those aged .70 years. 
This may suggest that the APOE effect becomes attenuated 
with age, allowing other determinants of cognitive function 
such as PA to become more apparent. Similar to the cogni-
tively beneficial effects of PA observed in non-ε4 carriers in 
our study, Podewils et al demonstrated that performance of 
$4 types of activity lowered dementia risk at age $ 65 years 
in the Cardiovascular Health Cognition Study, an effect that 
was marked in non-ε4 carriers but absent in ε4 carriers.19 
Conversely, we confirmed a lack of association of PA with 
cognitive performance in ε4 carriers in the 60–69 age group. 
Persons suffering from serious medical illnesses may perform 
at lower levels of PA and have lower cognition. However, 
the statistically significant association of PA with enhanced 
cognition at age 60–69 years in our final model suggests that 
the association of PA with enhanced cognition in the younger 
non-ε4 carriers is likely independent of mobility limitation 
and chronic medical illnesses.
An additional important finding from this study is the 
improved performance in the .70 age group exercisers 
compared with nonexercisers in all genotype groups, sug-
gesting that the favorable effects of PA in this group may 
not be significantly influenced by the ε4 allele of the APOE 
gene (Figure 2). The favorable effects of PA on memory 
in non-ε4 carriers remained unaltered, notwithstanding 
adjustment for serious chronic medical illness, but not 
after accounting for the effect of mobility limitation. 
However, a three-group (ε4-homozygote, ε4-heterozygote, 
and   noncarriers) analysis to confirm that PA can enhance 
cognition at age $ 70 years regardless of genotype group 
was constrained by sample size.
Because mobility limitation is a surrogate marker for 
PA, its significant association with poorer performance on 
cognitive tests after discounting the effects of serious chronic 
medical illness supports its role as an indicator of sedentary 
lifestyle. Previously, it was suggested that pathologies 
underlining frailty may partially explain the association of 
low levels of PA with poor cognitive performance.46 The 
coexistence of frailty with serious chronic medical condition 
and low BMI prompted us to examine their contributions to 
cognitive outcome in our sample. However, the significant 
effect of PA after adjustments for serious chronic medical 
conditions and BMI, makes frailty a less tenable explanation 
for our findings in older adults but supports mobility limita-
tion as a surrogate marker for low levels of PA. Given the 
nonspecific pattern of association of APOE genotype groups 
with limitation in physical function, this relationship prob-
ably does not explain our findings either.
Contrary to studies reporting a beneficial effect of PA 
and/or aerobic fitness on neurocognitive processes, few have 
reported negative results.47,48 Verghese et al reported that a 
one-point increment in the PA score did not significantly 
improve performance on cognitive tasks,47 and that levels of 
PA did not associate with incident amnestic mild cognitive 
impairment.48 However, the authors failed to account for a 
few important components of PA such as walking, garden-
ing/yard work, and house chores. Interestingly, our observa-
tion of no association in the 60–69 age group ε4-carriers is 
also analogous to the overall conclusions of Verghese et al, 
except that such subgroup analyses were not considered by 
the authors. Such methodological differences in the assess-
ments of cognition and PA may contribute to inconsistencies 
in the literature. In comparison with previous cross-sectional 
studies, this study has the advantage of adjustment for seri-
ous chronic illnesses and mobility limitation, is age-specific, 
and involves APOE genotype-stratified analysis in addition 
to a representative sample. Though the mechanisms by 
which APOE comediates differential PA-induced changes in 
cognition may involve its role in lipid metabolism, further 
clarification of this process is needed.
Advantages and limitations
NHANES-III is the largest study to provide population-
based data on the association of cognitive function and PA 
in a nationwide representative sample of older Americans. 
Because age is one of the most important risk factors for 
dementia, the relatively large sample size of the   NHANES-III 
permits age-stratified analysis, adjustment for multiple 
confounders, and, therefore, more detailed assessment of 
the relationship of PA with cognitive outcome. Limitations 
of this study include possible bias from survey nonresponse 
and from missing values for some variables and the large 
number without APOE data.
Due to its cross-sectional nature, the study does not   provide 
information on the temporal sequence of PA with SMSE score. 
For questionnaires administered in the Hispanic language, 
translational bias cannot be excluded in spite of rigorous staff 
training and standardizations. Randomized   controlled trials 
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using a more rigorous standardized aerobic exercise-training 
protocol together with detailed neuropsychological measures 
are needed to determine the duration, intensity, frequency, and 
ultimately the volume of exercise that are beneficial.
Conclusion
In a large national sample of noninstitutionalized Americans 
aged $60 years, PA associated with better cognitive outcomes. 
Between the ages of 60 and 69 years, this effect varied by 
APOE gene group, the effects being observed only in non-ε4 
carriers. Randomized controlled trials are needed to establish 
causality. Also, the APOE genotype or its genotype must be 
taken into account while designing such studies. These may 
lay the groundwork for the prescription of aerobic training as 
an intervention to attenuate AD risk in those at risk.
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